// App-Quantinova.ai

Sa1943 : Histopathologic Grading Using Poorly-Differentiated Clusters Predicts Outcome in Colorectal Carcinoma

Researchers

Presenter

  • Bojana Mitrovic

Principal Investigators

  • Kelly Handley

  • Richard Gray

  • Naziheh Assarzadegan

  • Gordon Hutchins

  • Philip Quirke

  • Robert H. Riddell

  • Richard Kirsch

Medical Centers

  • Pathology and Tumour Biology, Leeds Institute of Cancer & Pathology, Leeds, United Kingdom

  • BC Cancer Agency, Vancouver, BC, Canada

  • Clinical Trial Service Unit, Univ of Oxford, Oxford, United Kingdom

  • St Michael's Hospital, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • leucovorin

  • Adrucil injection

Outcome

  • N/A

Study Design

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved